Lilly Bamlanivimab Antibody Playbook

Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Related Content

Fiscal Year 2023 Omnibus Summary

This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.

Jan. 13, 2023

COVID-19 Emergency Declaration Timeline

This chart contains updated information on the various COVID-19 emergency declarations, including timelines, processes for renewal and current expiration dates.

Jan. 12, 2023

The Facts About COVID-19 and Children

Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.

Jan. 06, 2023